What is DSIP peptide?

DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Discovered in 1977 from rabbit cerebral venous blood by Schoenenberger and Monnier at the University of Basel, it weighs 849 daltons and crosses the blood-brain barrier. DSIP modulates slow-wave (delta) sleep architecture — the deepest, most restorative phase of sleep.

How does DSIP work for sleep?

DSIP works through multiple mechanisms: it mediates NMDA receptors to promote sleep-state transitions, activates the MAPK cascade for cellular stress regulation, suppresses cortisol through GILZ homology pathways, and stimulates growth hormone release via somatoliberin. Unlike sedatives, DSIP enhances natural sleep architecture rather than forcing unconsciousness.

What is the typical DSIP dosage?

DSIP is typically dosed at 100-500 mcg administered subcutaneously 30-60 minutes before bed. Common protocols include nightly dosing or 5-on/2-off cycling for 4-8 weeks. The dose-response relationship is non-linear — higher doses don

Does DSIP cause tolerance or dependency?

No. Multiple clinical trials, including the 1987 chronic insomnia trial, have demonstrated that DSIP does not produce tolerance, dependency, or withdrawal effects. This is one of its most significant advantages over pharmaceutical sleep aids like benzodiazepines and Z-drugs.

What is DSIP's half-life?

DSIP has an extremely short plasma half-life of 7-8 minutes, with an in-vitro half-life of approximately 15 minutes. Despite this rapid degradation, its sleep-modulating effects persist through downstream signaling cascades (MAPK, gene expression changes) that outlast the peptide itself.

Is DSIP found naturally in the human body?

Yes. DSIP is an endogenous peptide found in the human brain and has been detected in human breast milk at concentrations of 10-30 ng/mL. This suggests it plays a natural role in sleep regulation and may contribute to the sleep-promoting effects of breastfeeding for infants.

How does DSIP compare to melatonin?

Melatonin is a circadian signal — it tells your body when to sleep but doesn

What are the limitations of DSIP research?

DSIP research has notable limitations: small sample sizes in clinical trials, most foundational studies from the 1980s-1990s era, limited modern replication of early results, and the 1992 double-blind study, while positive, needs larger-scale confirmation. DSIP remains a research compound without FDA approval.